An Advanced Antibody-Based Therapeutics Company

Immunomedics will become a leading and fully integrated biopharmaceutical company dedicated to building and commercializing a differentiated portfolio of targeted biologic therapies using science and the deep understanding of selected diseases to transform patient outcomes.


Our work is driven by scientific excellence and the highest standards, in a culture of integrity, pride and dedication. In doing so, we create value for our shareholders and a rewarding environment for our employees.

Read through our latest news to learn about our efforts to improve patient care.

See All News


Given our commitment to excellence and innovation, we strive to find the most talented individuals who can support our corporate mission of improving health and the quality of life of patients with novel therapeutics for the treatment of cancer, autoimmune and other serious diseases.

Get in touch to find out more about Immunomedics

Contact Us